GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ABCB1 | 40 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0604 | 30853342
|
ABCG2 | 74 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1739 | 30853342
|
ABCG2 | 74 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | FACs | NA | 0.28 | 0.1739 | 22948659
|
CXCR4 | 2561 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0498 | 30853342
|
CXCR4 | 2561 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | Gemcitabine | qPCR | NA | 0.28 | 0.0498 | 31440741
|
POU5F1 | 9221 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 30853342
|
SOX2 | 11195 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 30853342
|
PROM1 | 9454 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | FACs followed by MACs and Tumorigenicity assay | NA | 0.24 | 0.7582 | 27602113
|
PROM1 | 9454 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | Gemcitabine | qPCR | NA | 0.24 | 0.7582 | 31440741
|
PROM1 | 9454 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | SFA followed by FACs | NA | 0.24 | 0.7582 | 30853342
|
PROM1 | 9454 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | Gemcitabine | SFA followed by FACs | NA | 0.24 | 0.7582 | 19501590
|
ALDH1A1 | 402 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | Gemcitabine | qPCR | NA | 0.2 | 0.684 | 31440741
|
CD24 | 1645 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | Gemcitabine | qPCR | NA | 0.2 | 0.456 | 31440741
|
CD24 | 1645 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | FACs | NA | 0.2 | 0.456 | 22948659
|
CD24 | 1645 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | SFA followed by FACs | NA | 0.2 | 0.456 | 30853342
|
CD44 | 1681 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | Gemcitabine | qPCR | NA | 0.2 | 1 | 31440741
|
CD44 | 1681 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | FACs | NA | 0.2 | 1 | 22948659
|
CD44 | 1681 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | SFA followed by FACs | NA | 0.2 | 1 | 30853342
|
DCLK1 | 2700 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | Gemcitabine | qPCR | NA | 0.2 | 0.0159 | 31440741
|
EPCAM | 11529 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | Gemcitabine | qPCR | NA | 0.2 | 0.211 | 31440741
|
EPCAM | 11529 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | FACs | NA | 0.2 | 0.211 | 22948659
|
EPCAM | 11529 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | NA | SFA followed by FACs | NA | 0.2 | 0.211 | 30853342
|
NES | 7756 | LTM | Pancreatic Cancer | Adenocarcinoma | HPAF-II | Gemcitabine | qPCR | NA | 0.2 | 0.0573 | 31440741
|